Androgens Flashcards
1
Q
FSH and LH in Males vs Females
A
- FSH
- Females: Stimulates growth and development of ovarian follicules; promotes estrogen secretion by ovaries
- Males: Required for sperm production
- LH
- Females: responsible for ovulation, formation of corpus lutem, regulation ovarian secretion female sex hormones
- Males: cells in testes to create testosterone.
2
Q
Androgen Synthesis
A
- Prevenlant forms: androstenedione, testosterone, dihydroxtestosterone
- Androstenedione produced in testes, adrenal cortex, and ovaries
- Testosterone in the testes and ovaries
- Small amounts dihydroxtestosterone in the adrenal cortex
- Males have 40-60x more testosterone
- Females behaviorally more sensitive
- Testosterone is produced by Leydig cells
- In Sertoli cells, testeosterone for spermatogenesis
3
Q
Androgen Synthesis Pathway
A
4
Q
Physiological effects of androgens
A
-
Stimulates development of secondary sex characteristics
- growth of larynx/thickening of vocal cords
- Hair growth
- Penis/package growth
- Essential for spermatogenesis
- Maintains sexual function
-
Stimulates skeletal growth and epiphyseal closure
- Inhibits osteoporosis
- Largely through conversion to estrogen
- Increase lean body mass and decrease fat
- Decreases HDL levels
- Stimulates secretory proteins in liver and induces enzymes involved in drug metabolism
- Stimulates sebecous glands and hair follicles
-
Psychological and behavioral effects
- attention, memory, spatial ability
5
Q
Feedback Control in HPT
A
6
Q
Androgen Insensitivity Syndrome
A
-
Patients have X/Y male genotype but female phenotype
- Normal to high levels of estrogen and progesterone
- Infertile
- 1/60,000
-
Biochemical Mechanism
- Mutation in androgen receptor
- Receptor is X linked
- Typical partial function loss
- Total loss of function causes complete form:
- No uterus/ovaries
- Abdominal testes
- No pubic/axillary hair
- High estrogen levels
- Breast development
- Tall and athletic women
7
Q
Spinal Bulbar Muscular Dystrophy (Kennedy’s Disease)
A
- Affected males have muscle cramps and progressive weakness due to degeneration of motor neurons in the brain stem and spinal cord
- Age of onset/severity varies from adolescent to old age, mostly in middle adult life
- Doesn’t compromise longevity
- Neuromuscular and endocrine manifestations
-
Biochemal Mechanism
- Expansion of CAG (glutamine-Q) repeat in androgen receptor gene
- PolyQ repeat in androgen receptor protein
- Binding of polyQ AR to testosterone causes aggregation in neurons
- Length of polyQ determines age of onset (longer=earlier)
8
Q
Therapeutic Purposes of Androgens
A
- HRT
- Males with hypogonadism
- Gender reassignment
- Loss of testicular funx from disease/cancer
- Middle aged and older men
- Menopause
- Increase libido
- Treat bone density loss, lean mass
- Depression/low energy
- Endrometriosis
- Danazol (testosterone derivative) inhibits FSH and LH to decrease estrogen and atrophy ectopic tissue
- Chronic Wasting Condition
- HIV/cancer
- Male Contraceptive
- Testosterone and progestin trials are promising.
9
Q
Adverse Effects of Testosterone
A
- Virilization (females looking manly)
- Feminization (males)
- Precocious puberty
- Stunted growth
- Prostate enlargment
- Atherosclerosis
- Hepatic carcinoma
- Choelstatic jaundice
- Edema
10
Q
3 Strategies to Modulate Androgen Production
A
- GnRH analogs
- Act as GnRH recetor antagonists when administered continuously
- Decreases pitutiary secretion of LH and FSH
- Act as GnRH receptor agonists when administered pulsatile
- Increases pituitary LH and FSH
- Leuoprolide used to treat hormone-responsive cancer
- Breast/prostate
- Act as GnRH recetor antagonists when administered continuously
- 5 alpha reductase inhibitor
- Block conversion of testosterone to more potent dihydrotestosterone
- Increased testosterone and possibly estradiol
- Androgen Recetor Antagonist
- Prevent binding of testosterone and dihydroxytestosterone
11
Q
5 alpha reductase inhibitors
A
- Block dihydroxytestosterone production
- Finasteride blocks type 2 isozyme, dutasteride blocks both
- Used for
- Prostate cancer
- BPH
- Male patterened baldness
- Side Effects
- Libido loss
- ED
- Gyno
12
Q
Androgen Receptor Antagonist (steroidal)
A
- Spirnolactone, Cyproterone
- Prevent binding of testosterone and dihyrotestoterone to AR
- Used for
- Prostate cancer
- BPH
- Male patterened baldness
- Female hairness
- Priapism
- Hypersexuality
- Precoucius puberty
- Male-to-female transgender
- Side Effects
- Liver toxicity
- Adrenal funx suppression
- Depression
- Gyno
- ED
13
Q
Androgen Receptor Antagonist (Non-steroidal)
A
- Prevent binding of testosterone and dihydrotestoterone to AR
- Bicalutamide, Nilutamide, Flutamide
- Used for:
- Prostate cancer
- Female hairness
- Side Effects
- Gyno
- Tamoxifen can counter this
- Mild liver damage
- Reversed with discontinuation
- GI effects
- Bicalutamide better than flutamide
- Gyno